A multicenter, randomized, double-blind study comparing the clinical effects of intravenous montelukast with placebo in patients with acute asthma

Trial Profile

A multicenter, randomized, double-blind study comparing the clinical effects of intravenous montelukast with placebo in patients with acute asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Mar 2017

At a glance

  • Drugs Montelukast (Primary)
  • Indications Acute asthma
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 01 Feb 2010 Results published in Journal of Allergy and Clinical Immunology.
    • 01 Feb 2010 Primary endpoint 'Forced expiratory volume in 1 second' has been met.
    • 28 Jul 2008 Status changed from in progress to completed, as reported on clinicaltrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top